Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19

Overview

The purpose of this study is to determine whether patients with COVID-19 improve faster if they receive plasma from those who have recovered from COVID-19, because it may have the ability to fight the virus that causes COVID-19.

Description

Participants will receive plasma from a person who has recovered from COVID-19 with a compatible blood type.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    COVID-19
  • Age: Between 18 Years - 100 Years
  • Gender: All

Individuals at least 18 years of age with a laboratory confirmed diagnosis of COVID-19, with severe or life threatening disease.

Updated on 20 Nov 2022. Study ID: 2004191377

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center